Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Prescription Drugs

MasterPharm LLC: Finasteride Plus 1.25mg Capsules Recalled for Minoxidil Contamination

Agency Publication Date: May 14, 2020
Share:
Sign in to monitor this recall

Summary

MasterPharm LLC has recalled approximately 7,260 capsules of Finasteride Plus 1.25mg because they were found to be contaminated with minoxidil, a different medication used for blood pressure and hair growth. These compounded products were sold in 30-count and 90-count bottles throughout the United States. Consumers who have this medication should stop using it immediately and consult their doctor or pharmacist, as it contains a drug other than what was prescribed.

Risk

The presence of undeclared minoxidil in a product intended to be finasteride can cause serious side effects such as low blood pressure, rapid heart rate, and fluid retention. This cross-contamination means patients are unknowingly consuming a potent cardiovascular medication, which poses a significant health hazard.

What You Should Do

  1. Check your prescription bottle label to see if you have Finasteride Plus 1.25 mg Capsules in either 30-count or 90-count sizes.
  2. Look for Lot #02-27-2020:04@11 or Lot #02-27-2020 with an expiration date of August 25, 2020, to identify if your medication is part of the recall.
  3. Stop taking this medication immediately if it matches the affected lot and expiration information.
  4. Contact your healthcare provider or pharmacist right away to discuss your health concerns and to secure a safe replacement medication.
  5. Return any unused capsules to the pharmacy where you purchased them to receive a refund and further instructions on safe disposal.
  6. For more information, you can contact MasterPharm LLC at their location in South Richmond Hill, NY.
  7. If you have additional questions or wish to report a side effect, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Pharmacy refund and healthcare consultation

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund and contact the manufacturer for further instructions.

Affected Products

Product: Finasteride Plus 1.25 mg Capsule (30-count bottle)
Model:
Recall #: D-1269-2020
Lot Numbers:
02-27-2020:04@11 (Exp. August 25, 2020)
02-27-2020
Date Ranges: Exp. August 25, 2020
Product: Finasteride Plus 1.25 mg Capsule (90-count bottle)
Model:
Recall #: D-1269-2020
Lot Numbers:
02-27-2020:04@11 (Exp. August 25, 2020)
02-27-2020
Date Ranges: Exp. August 25, 2020

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 85619
Status: Resolved
Manufacturer: MasterPharm LLC
Sold By: MasterPharm; Pharmacies
Manufactured In: United States
Units Affected: 7260 capsules
Distributed To: Nationwide
Agency Last Updated: May 19, 2020

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.